NASDAQ Companies

Second Quarter Summary:Net loss of $5.9 million, or $0.50 per diluted share, compared with net income of $6.1 million, or […]

Two U.S. FDA approvals in second quarter 2020Second quarter 2020 total revenue of $61.7 million and Crysvita revenue in Ultragenyx […]

RICHMOND, Va., July 30, 2020 (GLOBE NEWSWIRE) — Kinsale Capital Group, Inc. (NASDAQ:KNSL) reported net income of $30.3 million, $1.33 […]

Provides Update on CPI-006 Phase 1 COVID-19 StudyConference Call Today at 4:30 p.m. ET / 1:30 p.m. PTBURLINGAME, Calif., July […]

ROCKVILLE, Md., July 30, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and […]

PLEASANTON, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of […]

BURNABY, British Columbia, July 30, 2020 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced […]

Enrollment ahead of schedule in Phase 3 PROTECT Study of sparsentan in IgAN; topline proteinuria data from both pivotal studies […]

YARDLEY, Pa., July 30, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose […]

NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on […]